Keros Therapeutics is Biotechnology in United States that focus on Keros Therapeutics Inc business. Founded in 2015. They cover business area such as Keros Therapeutics Inc, development, commercialization, novel treatment, patient, hematological and musculoskeletal disorder, high unmet medical need, low blood cell count, cytopenia, anemia, myelodysplastic syndrome, MDS, myelofibrosis.
2015
( 9 years old in 2024 )
Keros Therapeutics Inc
-
99 Hayden Avenue
Suite 120 (Building E)
Lexington, MA 02421
United States
Private
Keros Therapeutics Incdevelopmentcommercializationnovel treatmentpatienthematological and musculoskeletal disorderhigh unmet medical needlow blood cell countcytopeniaanemiamyelodysplastic syndromeMDSmyelofibrosis
* We use standard office opening hours in near Keros Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Keros Therapeutics is Biotechnology business from United States that founded in 2015 (9 years old in 2024), Keros Therapeutics business is focusing on Keros Therapeutics Inc.
Keros Therapeutics headquarter office and corporate office address is located in 99 Hayden Avenue Suite 120 (Building E) Lexington, MA 02421 United States.
Keros Therapeutics was founded in United States.
In 2024, Keros Therapeutics is currently focus on Keros Therapeutics Inc sector.
Above is snippet of Google Trends for "Keros Therapeutics Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Keros Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
